Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 25, 2013 - Issue 8
1,228
Views
54
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

The relationship between depression, anxiety and medication adherence among patients receiving antiretroviral treatment in South Africa

&
Pages 948-955 | Received 06 Feb 2012, Accepted 05 Nov 2012, Published online: 11 Dec 2012

References

  • Alfonso, V., Geller, J., Bermbach, M., Drummond, A., & Montaner J. S. G. (2006). Becoming a “treatment success”: What helps and what hinders patients from achieving and sustaining undetectable viral loads. AIDS Patient Care and STDs, 20, 326–334. doi:10.1089/apc.2006.20.326.
  • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (Rev. 4th ed.). Washington, DC: Author.
  • Ammassari, A., Antinori, A., Aloisi, M. S., Trotta, M. P., Murri, R., Bartoli, L., Monforte, A. A., … Starace, F. (2004). Depressive symptoms, neurocognitive impairment and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics, 45, 394–402. Retrieved from http://psy.psychiatryonline.org/cgi/reprint/45/5/394.
  • Beck, A. T., & Steer, R. A. (1993). Beck Anxiety Inventory (BAI): Manual, New York: The Psychological Corporation.
  • Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Beck Depression Inventory (Second Edition.). BDI II: Manual”. New York: The Psychological Corporation.
  • Brandt, R. (2009). The mental health of people living with HIV/AIDS in Africa: A systematic review. African Journal of AIDS Research, 8(2), 123–133. doi:10.2989/AJAR.2009.8.2.1.853.
  • Campos, L. N., Guimarães, M. D. C., & Remien, R. H. (2008). Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS and Behavior, 14, 289–299. doi:10.1007/s10461-008-9435-8.
  • Dalessandro, M., Conti, C. M., Gambi, F., Falasca, K., Doyle, R., Conti, P., … Vecchiet, J. (2007). Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. Journal of Clinical Psychopharmocology, 27, 58–61. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17224714.
  • Field, A. (2005). Discovering statistics using SPSS (2nd ed). London: Sage Publications Ltd.
  • Freeman, M., Nkomo, N., Kafaar, Z., & Kelly, K. (2008). Mental disorder in people living with HIV/AIDS in South Africa. South African Journal of Psychology, 383, 489–500. Retrieved from http://web.ebscohost.com.ez.sun.ac.za/ehost/pdfviewer/pdfviewer?vid=3&hid=10&sid=3e1c396e-5f62-4522-a060-dab9b6bfc5f1%40sessionmgr112.
  • Gordillo, V., Amo, J., Soriano, V., & González-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763–1769. Retrieved from http://journals.lww.com/aidsonline/Fulltext/1999/09100/Sociodemographic_and_psychological_variables.21.aspx.
  • Kagee, S. A. (2008). Adherence to antiretroviral therapy in the context of the national roll-out in South Africa: Defining a research agenda for psychology. South African Journal of Psychology, 282, 413–428. Retrieved from http://www.psyssa.com/documents/sapsyc.pdf.
  • Kagee, S. A., & Martin, L. (2010). Symptoms of depression and anxiety among a sample of South African patients living with HIV. AIDS Care, 22(3), 381–388. doi:10.1080/09540120903193690.
  • Mannheimer, S. B., Matts, J., Telzak, E., Chesney, M., Child, C., Wu, A. W., & Friedland, G. (2005). Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care, 17, 10–22. doi:10.1080/09540120412331305098.
  • Molassiotis, A., Nahas-Lopez, V., Chung, W. Y. R., Lam, S. W. C., Li, C. K. P., & Lau, T. F. J. (2002). Factors associated with adherence to antiretroviral medication in HIV-infected patients. International Journal of STD & AIDS, 13(5), 301–310. doi:10.1258/0956462021925117.
  • Myer, L., Smit, J., Le Roux, L., Parker, S., Stein, D. J., & Seedat, S. (2008). Common mental disorders among HIV-infected individuals in South Africa: Prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care and STDs, 22, 147–158. doi:10.1089/apc.2007.0102.
  • Nel, A., & Kagee, S. A. (2011). Common mental health problems and antiretroviral therapy adherence. AIDS Care, iFirst, 23, 1–6. doi:10.1080/09540121.2011.565025.
  • Olalla, P. G., Knobel, H., Carmona, H., Guelar, A., López-Colomés, J. L., & Caylà, J. A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 30, 105–110. Retrieved from http://journals.lww.com/jaids/Abstract/2002/05010/Impact_of_Adherence_and_HighlH_Active.14.aspx.
  • Reynolds, N. R., Testa, M. A., Marc, L. G., Chesney, M. A., Neidig, J. L., Smith, S. R., … Robbins, G. K. (2004). Factors influencing medication adherence beliefs and self-efficacy in persons naïve to antiretroviral therapy: A multicenter, cross-sectional study. AIDS and Behavior, 8, 141–150. doi:1090-7165/04/0600-0141/0.
  • Safren, S. A., O'Cleirigh, C., Tan, J. Y., Raminani, S. R., Reilly, L. C., & Otto, M. W. (2009). A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychology, 28(1), 1–10. doi:10.1037/a0012715.
  • Sethi, A. K., Cenlentano, D. D., Gange, S. J., Moore, R. D., & Gallant, J. E. (2003). Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clinical Infectious Diseases, 37, 1112–1118. doi:1058-4838/2003/3708-0017$15.00.
  • Simoni, J. M., Kurth, A. E., Pearson, C. R., Pantalone, D. W., Merrill, J. O., & Frick, P. A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior, 10, 227–245. doi:10.1007/s10461-006-9078-6.
  • Steele, S. I., & Edwards, D. J. A. (2008). Development and validation of the Xhosa translations of the beck inventories: Item analysis, internal consistency, and factor analysis. Journal of Psychology in Africa, 182, 217–226. Retrieved from http://eprints.ru.ac.za/1480/.
  • Tucker, J. S., Burnam, N. A., Sherbourne, C. D., Kung, F., & Gifford, A. L. (2003). Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. The American Journal of Medicine, 114(7), 573–580. doi:10.1016/S0002-9343(03)00093-7.
  • World Health Organization. (2003). Adherence to long-term therapies: Evidence for action. Geneva: Author. Retrieved from http://whqlibdoc.who.int/publications/2003/9241545992.pdf.
  • World Health Organization. (2009). Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector: Progress report. Geneva: Author. Retrieved from http://www.who.int/hiv/pub/2009progressreport/en.
  • Yun, L. W. H., Maravi, M., Kobayashi, J. S., Barton, P. L., & Davidson, A. J. (2005). Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. Acquired Immune Deficiency Syndrome, 38, 432–438. Retrieved from http://journals.lww.com/jaids/Abstract/2005/04010/Antidepressant_Treatment_Improves_Adherence_to.8.aspx.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.